OPY vs PFE · P/E 13, rev $1.43B vs P/E 20, rev $62.58B
Oppenheimer Holdings Inc (OPY) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
OPY currently screens at market cap $1.15B and trailing P/E 12.8. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the OPY and PFE stock pages for the full models.
Not investment advice.